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People with schizophrenia die on average 15–20 years earlier than age and gender
matched controls in the general population. An essential part of this excess mortality in
people with schizophrenia is caused by physical illnesses. Among the physical illnesses,
cardiovascular disease (CVD) has been identified as the most common natural cause of
death in up to 40–45% of the cases. Chronotropic incompetence (CI) is defined as the
inability of the heart to increase its beating frequency in proportion to increased physical
activity or higher metabolic demand. It is an established independent cardiovascular
risk factor for major cardiac events and overall mortality and might explain adaptation
intolerance of the cardiovascular system to even minor exercise courses. CI needs
objective exercise testing for definitive diagnosis and therefore represents a biological
marker indicating the integrity of the cardiovascular system. It was recently described in
patients with schizophrenia and might help explain the reduced physical fitness in these
patients and the inability of a subgroup of patients to benefit from exercise interventions.
In this study, we tried to replicate the occurrence of CI in an independent sample of
patients with schizophrenia and evaluated whether CI can be influenced by a continuous
endurance training of 12 weeks. Therefore, we re-analyzed the fitness testing data of
43 patients with schizophrenia and 22 aged and gender matched healthy controls.
Parameters of aerobic fitness and chronotropic response to exercise were calculated.
Patients with schizophrenia were less physically fit than the healthy controls and displayed
a significantly higher heart rate at rest. 10 of 43 patients with schizophrenia and no healthy
control subject were classified as chronotropically incompetent. Chronotropic response
to exercise did not change significantly after 12 weeks of continuous aerobic exercise
training. No differences were observed for baseline heart rate and peak heart rate in
both subgroups of schizophrenia patients. Aerobic fitness did not improve significantly
in the patients with schizophrenia classified as chronotropically incompetent. Our results
confirm the occurrence of CI in patients with multi-episode schizophrenia. This should
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be taken into account when planning an exercise or lifestyle intervention studies in
this population. Schizophrenia patients with CI do not seem to benefit as well as
schizophrenia patients without CI from aerobic exercise training interventions. Larger,
prospective randomized controlled clinical trials with different training interventions are
urgently needed to address the topic of schizophrenia patients not responding to exercise
and the relationship to the illness itself.
Keywords: schizophrenia, exercise, chronotropic incompetence, cardiac autonomic dysfunction, heart rate
response
INTRODUCTION
There is a solid body of evidence underpinning the notion that
people with schizophrenia die on average 15–20 years earlier than
age and gender matched controls in the general population (1–3).
This mortality gap between the general population and patients
with schizophrenia seems to increase instead of converge over
the last decades (4–6). An essential part of this excess mortality
in people with schizophrenia is caused by physical illnesses (7–
9). In several studies, cardiovascular disease (CVD) has been
identified as the most common natural cause of death in up to
40–45% of cases (7, 10). It has been suggested that coronary heart
disease is the main contributor to CVD, which is exacerbated
by the high-risk profile (obesity, poor diet, lack of exercise,
smoking) of most patients with schizophrenia. In addition,
patients with schizophrenia take antipsychotic medication on
a regular basis, which is known to affect the cardiovascular
system additionally (11). Some of the risk factors are potentially
reversible by changing the lifestyle and even by considering
side effects of some antipsychotics. A non-pharmacological
interventional approach to impact cardiovascular risk factors
is regular physical exercise (12, 13). As mentioned above,
studies have shown that people with severe mental illness like
schizophrenia engage in significantly more sedentary behavior
and significantly less physical activity compared to healthy
controls (14). Additionally to somatic health benefits, aerobic
exercise positively impacts core features of the disease itself
like cognitive deficits (15–17) and negative symptoms (18).
However, although the above-mentioned risk factors seem to be
plausible they do not explain the excess mortality of patients
with schizophrenia satisfactorily. Moreover, psychiatrists and
researchers seem to overlook to some extend the solid body of
evidence describing cardiovascular dysregulation in patients with
schizophrenia both at rest and during physical activity. It has
been shown that young unmedicated patients with schizophrenia
show increased heart rates at rest caused by severe autonomic
dysfunction (19). An increase in heart rate of 5 beats per minute
corresponds to a significant increase in the atherosclerosis
progression (20). Life expectancy in animals and humans shows
a close relation to the medium heart rate (21). Increased resting
heart rate has been shown to be a risk factor for reduced
life expectancy in both the general population (22, 23) and in
populations with cardiovascular diseases (24, 25). In patients
with schizophrenia, the protective vagal component seems to
be profoundly impaired leading to reduced heart rate variability
or an insensitive baroreflex. While similar findings have been
described in patients with depression (26), alcohol withdrawal
(27), or anxiety disorders (28) the pronounced degree of changes
leads to a unique pattern in patients with schizophrenia. Most
of the described alterations in the autonomic nervous system
are associated with reduced life expectancy previously shown in
various conditions such as diabetes (29), survival aftermyocardial
infarction (30, 31) or in cardiac artery disease (CAD) (32).
Thus, more research is needed to better explain cardiovascular
dysregulation in schizophrenia because in contrast to patients
suffering from severe CAD the cardiac autonomic dysfunction in
schizophrenia is not caused by structural or functional alterations
of the heart itself but moreover by abnormalities in the brain—
heart interaction (33).
More recently, we investigated the putative link between
autonomic dysfunction and physical incapacity in these patients.
And indeed, Herbsleb et al. (34) were able to present
evidence that about half of the tested population of patients
with schizophrenia showed a strikingly absent heart rate
acceleration during physical exercise. This phenomenon is called
chronotropic incompetence of the heart (CI) and was again
described in various cardiac conditions (35–38). It is defined
as the inability of the heart to increase its beating frequency
in proportion to the increase in physical activity or higher
metabolic demand and therefore needs an exercise testing of the
patients for definitive diagnosis (37). This finding is of paramount
importance since CI is a well-described cardiac risk factor of
mortality (39–43), it is associated with physical incapacity and
might explain to some extend that patients with schizophrenia
encounter difficulties to enjoy physical activities. However, this
new finding warrants further studies to identify patients at risk
and to investigate treatment options.
Therefore, the aim of the current investigation was to examine
if the previously revealed impaired heart rate response to
physical exercise is a consistent finding, which can be also
detected in a further cohort of patients with schizophrenia.
Here, we used a different exercise test protocol in order to
elucidate the possibility to include data from various studies
and to generalize findings. In addition, we evaluated, whether
heart rate responses to exercise can be influenced by a
moderate-intensity continuous endurance training of 12 weeks
in our patients.
We hypothesized that (i) our re-analysis of fitness testing
data would reveal CI in a substantial portion of patients with
multi-episode schizophrenia, (ii) that CI is again related to
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reduced physical fitness in this subset of patients, and (iii) that an
continuous aerobic exercise training ameliorates or reverses the
CI of the heart in the subset of schizophrenia patients affected.
MATERIALS AND METHODS
Subjects
The evaluated cohort consisted of forty-three multi-episode
schizophrenia patients and twenty-two healthy controls
who successfully completed an interventional, single center
continuous aerobic exercise study which took place at the
Department of Psychiatry and Psychotherapy at the University
Medical Center Göttingen between 2010 and 2013 (44–48).
The local ethics committee approved the study protocol,
which was in accordance with the Declaration of Helsinki.
All participants provided written informed consent prior
to inclusion in the study. The trial was registered at www.
clinicaltrials.gov (NCT01776112). Briefly, 43 patients with multi-
episode schizophrenia and 22 healthy controls were assessed
for endurance capacity using an incremental exercise test on
a bicycle ergometer before and after the study intervention.
The study intervention consisted of standardized continuous
endurance training on cycle ergometers three times a week for
30min over a total intervention period of 12 weeks. A group
of 21 patients with schizophrenia played table soccer (also
known as foosball is the US) as an additional active control
intervention. Healthy controls were matched regarding age
and gender to patients in the endurance group (see Table 1).
Inclusion criteria were a diagnosis of schizophrenia according to
ICD-10, stable psychopathology and antipsychotic medication
for 2 weeks prior to the intervention and age between 18 and
60 years. Exclusion criteria were substance abuse (alcohol and
illicit drugs (cannabis, amphetamines, cocaine, benzodiazepines,
and opioids) assessed with urine drug tests), a worsening of
psychopathological symptoms within 2 weeks of the screening
period, pregnancy, lactation, or contraindications for endurance
training or maximal cardiopulmonary exercise testing (CPET).
Exercise Testing
In order to measure aerobic endurance capacity before and after
the 12-week intervention, participants performed incremental
CPET until subjective exhaustion on an electronically braked
bicycle ergometer (Ergoselect 200K, Ergoline GmbH, Bitz,
Germany). After a resting period of 3min, the incremental
bicycle protocol started at a power output of 25, 50, or 75W on
the basis of the anamnestic information for 3min. The power
output was then increased in steps of 25W every 3min until
the subject reached his or her limit of tolerance. During the
CPET, ventilatory indices and gas exchanges and heart rate
were measured continuously on a breath-by-breath basis using
an automatic mobile wireless ergospirometer (MetaMax 3B,
Cortex, Biophysik GmbH, Leipzig, Germany, and T31, Polar
Electro Oy, Kempele, Finland). Before each test, the turbine
(flow and volume) was calibrated with a syringe (Hans Rudolph
Inc., Kansas City). For data analysis, the breath-by-breath gas
exchange and ventilatory data were smoothed using a 15-breath
moving average, aligned to the time of the central breath. Peak
TABLE 1 | Baseline characteristics as well as parameters of aerobic fitness in the
control and patient group.
Baseline characteristic Controls Patients P-value
n = 22 n = 43
EPIDEMIOLOGICAL DATA
Age; years 37.6 ± 11.3 36.3 ± 12.9 0.589
Gender: male/female 16/7 31/12 0.743
Body mass; kg 80.8 ± 13.6 90.4 ± 19.2 0.052
BMI; kg/m2 26.0 ± 3.7 28.4 ± 4.9 0.023
DISEASE SPECIFIC DATA
Duration of disease (years) NA 10.9 ± 9.3 -
PANSS NA 69.3 ± 6.3 -
MEDICATION
Chlorpromazine equivalents, CPE
(mg/d)
NA 658 ± 674
Clozapin (yes/no) NA 5/38
PARAMETERS OF AEROBIC FITNESS
Peak oxygen uptake; ml/kg/min 35.9 ± 7.5 29.5 ± 8.7 0.011
Peak oxygen uptake; % pred 93 ± 22 113 ± 26 0.001
Peak power output; W/kg 2.54 ± 0.48 1.87 ± 0.54 <0.001
PWC 130; W/kg (patients: n = 40) 1.32 ± 0.36 1.09 ± 0.32 0.013
PWC 150; W/kg (patients: n = 42) 1.76 ± 0.38 1.44 ± 0.44 0.009
Power output at Lactate
Threshold; W/kg
1.28 ± 0.24 1,00 ± 0.32 0.001
OBJECTIVE EFFORT
Peak blood lactate, mmol/l 9.6 ± 2.7 7.6 ± 2.6 0.005
HEART RATE DATA AND CHRONOTROPIC RESPONSE
Baseline heart rate; 1/min 78 ± 10 90 ± 15 0.001
Peak heart rate; 1/min 180 ± 14 171 ± 18 0.069
% pred. heart rate reserve 98 ± 12 88 ± 18 0.017
Slope metabolic-chronotropic
relationship
1.05 ± 0.11 0.91 ± 0.20 <0.001
Chronotropic incompetence
(yes/no)
0/22 10/33 0.014
Data are shown as mean ± standard deviation or absolute number.
n, number of participants if not all are include in calculation because of excluded or missing
data (e.g., failure to reach a given heart rate); NA, not applicable.
Bold values indicate significant differences between groups.
oxygen consumption (VO2peak) was defined as the highest value
of 15-breath average occurring during CPET. Capillary whole-
blood samples of 0.2 µl were obtained for lactate measurements
from the ear lobe when the patient was at rest, and again at the
end of the third minute of each 3-min period of the CPET. The
blood lactate concentrations were measured by Lactate SCOUT
Solo Plus, SensLab GmbH, Leipzig, Germany).
Parameters of Aerobic Fitness
A set of different physiological maximal and submaximal indices
was used to describe the aerobic fitness. We calculated the power
output at a fixed heart rate of 130 and 150 (known as physical
working capacity; PWC 130, PWC 150), as well as the power
output at the Lactate Threshold (LT), which are both submaximal
indices of aerobic fitness. The time course of lactate was
graphically interpolated using an equalizing spline procedure.
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The LT was defined as the minimum lactate equivalent (the
lowest value of the quotient lactate to power output) as describes
the first sustained increase in blood lactate concentration above
resting level during incremental exercise (49). The evaluation
of the LT and the power output achieved at a blood lactate
concentrations of 2 mmol/l (for training prescription) were
done examiner independent by using a software for performance
diagnostic (Ergonizer, Germany, www.ergonizer.de). Moreover,
we determined the achieved peak power output (Ppeak) and peak
oxygen uptake (VO2peak). More details for the calculation of the
PWC, VO2peak, and Ppeak are given in Keller-Varady et al. (45).
Continuous Endurance Training
The interventions in the patients with schizophrenia consisted
of a 12-week training procedure. Participants participated in
three training sessions per week lasting exactly 30min each. The
sessions consisted of moderate-intensity endurance training on
cycle ergometers. The exercise intensity was set to the individual
power output achieved at a blood lactate concentrations of
2 mmol/l, determined during the preceding CPET. Power
output was than increased gradually, corresponding to
improvements in endurance performance, by a mean of 8
± 1 % after 11 ± 6 training sessions, controlled by lactate
concentration monitoring.
Assessment of Heart Rate Responses to
Exercise
To assess chronotropic response, the metabolic-chronotropic
relationship (MCR; also known as the chronotropic index)
was calculated according to (50) using the ratio of heart rate
reserve (predicted HRpeak (220—age)—HR at rest) to metabolic
reserve (VO2peak—VO2 at rest) during the CPET. The MCR
adjusts for age, physical fitness and functional capacity and is
unaffected by the exercise protocol as well as effort-independent
(37). The increase in percentage heart rate reserve in relation
to the increase in percentage metabolic reserve (also known as
oxygen uptake reserve) was obtained by linear regression analysis
using the least squares method of the mean values acquired
for VO2 and HR data in the last 30 s of each incremental
step of the CPET. In healthy adults, the percentage of heart
rate reserve achieved during exercise equals the percentage of
metabolic reserve achieved, so that the median MCR slope is
near around 1.0 with a 95% confidence interval between 0.8
and 1.3 (50).
Statistics
For statistical analysis, SPSS for Mac (version 25.0.0.1) was
used. All parameters were tested for normal distribution with
the Kolmogorov–Smirnov test or with Shapiro-Wilk-Test by
subgroup analysis. Epidemiological data and objective effort
during exercise testing of patients and controls as well as
subgroups of patients (CI vs. non CI patients) were compared
by either using parametric or non-parametric two-sample tests
as well as Chi-squared tests for comparison of nominal data.
To investigate basic differences of aerobic fitness and heart rate
parameters between all patients and controls, we performed
two separate multivariate analyses of variance (MANOVAs).
We conducted a first MANOVA for aerobic fitness parameters
with the inter-subject factor GROUP (patients vs. controls)
including VO2peak, Ppeak, PWC 130, PWC 150, as well as LT (all
normalized to body mass) followed-up by univariate analysis of
variances (ANOVAs). The second MANOVA for all participants
was performed by applying the factor GROUP (patients vs.
controls) and included the following heart rate parameters:
baseline heart rate, peak heart rate, and percentage of the
predicted heart rate reserve (% pred. heart rate reserve). ANOVAs
were then calculated for single parameters. To investigate the
main hypothesis of our study, the metabolic–chronotropic
relationship slope (MCR slope) of patients and controls was
analyzed. Controls and patients with a MCR slope below the
cut-off value of 0.8 were referred as chronotropic incompetent
whereas subjects with a MCR slope above a value of 0.8 were
classified as chronotropic competent (50). Group differences
of the MCR slope between patients and controls were verified
with a parametric two-sample t-test. We repeated a MANOVA
with respect to physical fitness for the factor SUBGROUP
(CI vs. nonCI patients) followed-up by univariate ANOVAs.
Due to the influence of chronotropic incompetence on the
heart rate derived fitness indices PWC 130 and PWC 150, we
abstained form including these parameters in the analysis. The
effects of the continuous aerobic endurance training on aerobic
fitness indices (including VO2peak, Ppeak, PWC 130, PWC
150, and LT) in subgroups of patients (CI vs. nonCI) were
examined using the dependent sample t-test or the Wilcoxon
matched pairs signed rank test as the nonparametric alternative.
We applied the same procedure to investigate the effects of
training MCR-slope in CI and non-CI patients. The significance
level was set 0.05 (two-sided) and fitted using Bonferroni
adjustment procedure to account for inflation of alpha level by
multiple testing.
RESULTS
Physical Fitness
The MANOVA for aerobic fitness indices (VO2peak, Ppeak,
PWC 130, PWC 150, LT) revealed a significant difference [F(5, 56)
= 5.66; P< 0.001] between all schizophrenia patients and healthy
controls. The follow-up univariate ANOVAs indicated significant
differences for VO2peak (F = 6.93; P < 0.05), Ppeak (F = 21.84;
P < 0.001), PWC 130 (F = 6.57; P < 0.05), PWC 150 (F = 7.35;
P < 0.01 and LT (F= 11.38; P < 0.01; see Table 1).
Heart Rate
The second MANOVA for heart rate parameters revealed a
significant effect for the factor GROUP [F(3, 61) = 6.45; P <
0.01]. As depicted in Table 1, the ANOVAs showed significant
differences between all patients and controls for baseline heart
rate (F = 11.60, p < 0.01) and percentage of predicted heart rate
reserve (F = 6.02, P < 0.05), whereas only a trend was found for
peak heart rate (F = 3.42, P < 0.069).
Metabolic–Chronotropic Relationship
Based on cut-off values by Burbaker and Kitzman, (37) and
Wilkoff and Miller, (50), 10 of 43 patients with schizophrenia
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FIGURE 1 | Mean ± 90% confidence limit of the metabolic–chronotropic
relationship of patients with (CI) and without (non-CI) chronotropic
incompetence as well as control subjects. The dotted line represents the lower
limit of normal (slope < 0.8).
had an impaired heart rate response to exercise and were
classified as chronotropically incompetent, whereas no healthy
control subject was below the cut-off value. Furthermore, a
significant difference was observed between the mean MCR
slopes of patients and controls (P < 0.001, see Table 1 and
Figure 1). The MANOVA that compared aerobic fitness indices
(VO2peak, Ppeak, and LT) between subgroups of patients
(CI vs. nonCI patients) revealed no significant difference
between groups [F(3, 39) = 1.76; P = 0.170] (see Table 2
and Figure 2).
Influence of the Moderate Intensity
Continuous Aerobic Exercise Training on
Heart Rate Response to Exercise
The MCR-slope as an index of chronotropic response to exercise
did not change significantly in both, the CI and the non-CI
subgroup after 12 weeks of continuous aerobic exercise training
compared to baseline (see Table 3). Furthermore, no differences
were observed for baseline heart rate and peak heart rate in
both groups.
Responses of Aerobic Fitness to
Continuous Aerobic Exercise Training
Of the 22 schizophrenia patients who underwent the 12-
week continuous aerobic exercise training intervention, 6 were
classified as chronotropic incompetent based on the MCR-Slope
as described above. The epidemiological data, aerobic fitness and
heart rate parameters are highlighted in Table 3. Aerobic fitness
improved significantly (as indicated by Ppeak, PWC 130, PWC
150) in the non-CI group, but contrary to our initial hypothesis
it did not change significantly in the CI-group (see Table 3).
However, no significant responses to training in both groups were
observed for VO2peak and LT.
TABLE 2 | Baseline characteristics as well as parameters of aerobic fitness in
patients with schizophrenia with (SZ-CI) and without chronotropic incompetence
(SZ-nonCI).
Parameters NonCI-
patients
CI-patients P-value
n = 33 n = 10
EPIDEMIOLOGICAL DATA
Age; years 37.4 ± 13.5 34.0 ± 11.3 0.542
Gender: male/female 22/11 9/1 0.150
Body mass; kg 87.2 ± 15.4 101 ± 27 0.204
BMI; kg/m2 27.6 ± 4.1 31.3 ± 6.2 0.033
DISEASE SPECIFIC DATA
Duration of disease (years) 10.7 ± 9.8 11.6 ± 8.0 0.702
PANSS 70.0 ± 6.6 67.1 ± 5.5 0.724
MEDICATION
Chlorpromazine equivalents, CPE
(mg/d)
624 ± 632 767 ± 822 0.687
Clozapin (yes/no) 2/31 3/7 0.039
PARAMETERS OF AEROBIC FITNESS
Peak oxygen uptake; ml/kg/min 30.9 ± 8.6 25.2 ± 7.5 0.067
Peak oxygen uptake; % pred 98 ± 21 74 ± 19 0.003
Peak power output; W/kg 1.97 ± 0.52 1.54 ± 0.49 0.027
Power output at Lactate
Threshold; W/kg
1.06 ± 0.33 0.83 ± 0.21 0.017
PWC 130; W/kg (CI: n = 9; nonCI:
n = 31)
1.08 ± 0.33 1.14 ± 0.29 0.601
PWC 150; W/kg (CI: n = 9) 1.39 ± 0.45 1.61 ± 0.34 0.188
OBJECTIVE EFFORT
Peak blood lactate, mmol/l 7.9 ± 2.6 6.4 ± 2.3 0.089
HEART RATE DATA AND CHRONOTROPIC RESPONSE
Baseline heart rate; 1/min 88 ± 15 92 ± 7 0.629
Peak heart rate; 1/min 177 ± 14 154 ± 17 <0.001
% pred. heart rate reserve 95 ± 13 64 ± 13 <0.001
Slope metabolic-chronotropic
relationship
0.98 ± 0.14 0.65 ± 0.15 <0.001
Data shown as mean ± standard deviation or absolute numbers.
n, number of participants if not all are include in calculation because of excluded or missing
data (e.g., failure to reach a given heart rate).
Bold values indicate significant differences between groups.
DISCUSSION
Our study shows in agreement with previous reports that
healthy controls show better fitness levels than patients with
schizophrenia, despite being age and gender matched and
engaging in no sports 2 years before entering the study (45).
In addition, this study confirmed in 10 out of 43 patients
the pattern of chronotropic incompetence in patients with
schizophrenia and thus corroborates the first description in
the disease although studied in a different fitness test design.
Most intriguingly, we did not observe a significant impact of a
twelve-week moderate continuous exercise training on CI values
in patients.
In the present study, we identified impaired chronotropic
responses with a step-wise incremental exercise test in contrast
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FIGURE 2 | Mean ± 90% confidence limit of peak oxygen uptake of all
patients, and patients with (CI) and without (non-CI) chronotropic
incompetence are depicted in comparison to controls. The dotted horizontal
lines represent contemporary age, gender, and body size specific reference
percentiles (51). Significant or a trend differences are indicated by *p < 0.05 or
(*) p < 0.1, respectively.
to the ramp-wise protocol used in the previous study by Herbsleb
et al. (34). However, in this independent sample only 23% of
the multi-episode patients with schizophrenia showed CI. This
is lower than in our previous study where the proportion of SZ-
CI consisted of 43% (34). The difference to higher share of CI
cases in our previous study may relate to the composition of
groups rather than other causes given the small sample size. It
seems not plausible that the cause of the higher occurrence of
CI in the study of Herbsleb et al. (34) is mainly explained by
the different exercise test protocols that were used. Although
the ramp-wise protocol results in lower mean HR as well as
VO2 values at the common power output than step-wise tests
[(52), the impact of the test protocol on the MCR slope (which
is the relationship of HR and VO2 values) is considered to be
negligible. A variety of exercise testing protocols and modes
of testing have been used to evaluates the MCR relationship
(37) since the originally description by Wilkoff and Miller
(50), that used a step-wise incremental treadmill exercise test.
However, in order to adequately assess the chronotropic response
to metabolic stress of exercise the following points should be
considered in future study designs: (i) participants should be
encouraged to exercise until the subject reaches his or her limit
of tolerance, (ii) exhaustion levels should be objectively evaluated
by either measuring blood lactate values or the respiratory
exchange ratio (ratio of carbon dioxide output to oxygen uptake),
(iii) a sophisticated gas-exchange analysis is needed or specific
test protocols (e.g., Bruce treadmill protocol, Chronotropic
Assessment Exercise Protocol) should be applied and iv) a step-
wise incremental exercise test with stage durations ≥3min is
recommended to obtain a near steady-state heart rate and to
satisfy the equations conditions.
Since CI is known to be a cardiac risk factor larger trials
might even elucidate possible clinical key factors associated
with CI. To date, we were unable to find a substantial
TABLE 3 | Differences to baseline in disease specific data, indices of aerobic
fitness, and heart rate data after a 12-week moderate-intensity aerobic training in
patients without (SZ-nonCI) and with (SZ-CI) chronotropic incompetence.
Training
nonCI-patients
Training
CI-patients
n = 16 n = 6
EPIDEMIOLOGICAL DATA
Body mass; kg −0.9 ± 5.2 −0.5 ± 9.1
BMI; kg/m2 −0.2 ± 1.6 0.0 ± 2.6
DISEASE SPECIFIC DATA
PANSS −8.9 ± 18.6* 7.0 ± 13.5
MEDICATION
Chlorpromazine equivalents, CPE
(mg/d)
−2 ± 473 212 ± 552
PARAMETERS OF AEROBIC FITNESS BEFORE AND AFTER TRAINING
Peak oxygen uptake; ml/kg/min 1.52 ± 5.24 0.45 ± 5.42
Peak oxygen uptake; % pred 4.8 ± 15.7 2.0 ± 16.0
Peak power output; W/kg 0.18 ± 0.23*# 0.09 ± 0.43
PWC 130; W/kg (non CI: n = 15,
CI: n = 5)
0.20 ± 0.26*# −0.00 ± 0.37
PWC 150; W/kg (CI: n = 5) 0.22 ± 0.26*# 0.08 ± 0.43
Power output at Lactate
Threshold; W/kg
−0.02 ± 0.32 0.05 ± 0.24
OBJECTIVE EFFORT
Peak blood lactate; mmol/l 0.83 ± 1.66 0.83 ± 2.83
HEART RATE DATA AND CHRONOTROPIC RESPONSE
Baseline heart rate; 1/min −4.7 ± 13.4 −6.1 ± 7.1
Peak heart rate; 1/min 0.0 ± 10.4 −0.5 ± 18.8
% pred. heart rate reserve 0.1 ± 13.1 3.4 ± 17.0
Slope metabolic-chronotropic
relationship
0.01 ± 0.14 0.02 ± 0.20
Data are shown as mean ± standard deviation.
n = number of participants if not all are include in calculation because of excluded or
missing data (e.g., failure to reach a given heart rate), * and # indicates statistically
significant difference from baseline values, P < 0.05 (*not adjusted/*#adjusted for
multiple testing).
Bold values indicate significant differences before and after training within a group.
difference between CI and non-CI patients with respect to
psychopathology, body mass index, duration of disease or
the prescribed medication (see Table 1). However, it should
be noted that patients taking clozapine were not included in
the first analysis and the putative influence of clozapine on
cardiovascular regulation should be investigated separately in
future studies.
Various pathophysiological mechanisms have been proposed
leading to chronotropic incompetence in cardiac conditions.
For instance, Bristow and colleagues found a 50% or greater
reduction in β-adrenergic receptor density in the left ventricular
myocardium of failing hearts explanted during transplant surgery
(53). These and other findings suggest that in heart failure
patients, a decrease in β-receptor density leads to a diminished
sensitivity of the β-adrenergic pathway and a decrease in
β-agonist–stimulated muscle contractility. We would like to
speculate that the long lasting augmented sympathetic drive
might lead to a reduction of β-receptor density in patients with
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schizophrenia. In addition, we cannot exclude that the chronic
stress of a multi-episode disease such as schizophrenia might
be associated with reduced excretion of catecholamines during
an exercise bout. Although we have not observed a difference
between both patient groups with respect to medication
(34), we cannot completely exclude that anti-dopaminergic
activity of some antipsychotics might influence the acute stress
response. Since the definite pathophysiology of schizophrenia
remains unclear, concepts of neuroinflammation and specifically
autoimmune encephalitis or autoimmune psychosis have again
gained more ground recently (54–57). However, the definite
contribution is still discussed controversially, especially in those
cases with no neurological symptoms (58). For the diagnosis
of Autoimmune-Encephalitis clinical, imaging and CSF criteria
have been proposed (59). Autoimmune antibodies are known
to cause autonomic dysfunction in a lot of diseases like
Sjögren syndrome or Guillain–Barré syndrome but also in
conditions called pure autonomic failure (60). To the best of
our knowledge the patients with multi-episode schizophrenia
included in this study showed no yellow or red signs pointing to
autoimmune etiology (61). Nevertheless, autoimmune antibodies
were not studied specifically in the cerebrospinal fluid prior
to inclusion in the study and hence cannot be ruled out
to cause or promote autonomic dysfunction, here described
as CI, in a subgroup of the patients. Nevertheless, CI could
be a relatively easy to obtain objective biological marker to
study the conjunction with inflammation pathways. Thus, this
should be elucidated in further studies in this field and shift
the focus on pathophysiological mechanisms to understand
regulatory problems in patients with schizophrenia. This might
help to decrease some obstacles impeding patients to engage
in physical activities on a regular basis and to benefit from
it (62). If CI is of importance in a substantial subset of
patients with schizophrenia then one needs to think about other
routines to accustom patients with schizophrenia to regular
physical activity.
It is therefore intriguing that 12 weeks of continuous aerobic
exercise training had no impact on CI measures in this study
and that patients with multi-episode schizophrenia and CI did
not benefit from the regular aerobic exercise in terms of fitness
parameters or heart rate at rest. More studies are urgently needed
to learn how to modulate the cardiac risk factor CI in patients
with schizophrenia. One needs to consider different exercise
protocols, longer durations of exercise and adjustments as well
as an optimal assessment of CI in the first place. In addition,
we need to learn the influence of antipsychotic medication
on CI. Especially promising might be the application of high
intensity training, which seems to be feasible in patients with
schizophrenia (63–66). Herbsleb et al. (67) showed in an case
report that a 6-week high intensity training improved autonomic
function substantially while no such effect was observed after 6
weeks of continuous training in a patient with schizophrenia.
Most intriguingly, the previously observed pattern of autonomic
dysfunction returned after 6 weeks of detraining. This study
underlines the importance of the choice of the training method
as well the introduction of long-lasting training concepts
in psychiatry.
Some limitations need to be taken into account. This is
an exploratory secondary analysis of the fitness testing results
of previously published data (44–46). Though the initial study
protocol (44) was not primarily designed to reveal CI it contained
thorough fitness testing [executed by a trained sports scientist
(KKV)] to objectively assess cardiovascular fitness levels in the
included patients with schizophrenia before and after the exercise
intervention. However, the obtained data allowed us to calculate
the metabolic-chronotropic relationship and hence CI post-hoc.
As outlined above, the presence of CI can detected regardless
the protocol (continuous or step-wise increase of the workload)
during formal exercise testing and a variety of exercise testing
protocols can be used (37, 52). This is of high interest when
re-analyzing fitness testing data of existing exercise studies to
shed more light on the phenomenon of exercise intolerance in
patients with schizophrenia and to determine to which extend CI
might be a contributing factor. The sample size is relatively small,
especially those of SZ-CI that underwent 12 weeks of continuous
aerobic exercise training.
CONCLUSION
Our results confirm the occurrence of CI in patients with multi-
episode schizophrenia. Thorough fitness testing is necessary
to reveal CI, but it does not seem to make a difference
if the workload during the test is raised continuously or
stepwise every 3min. This should be taken into account
when planning an exercise or lifestyle intervention study
in patients with schizophrenia. Further studies are also
needed to confirm CI in a prospective sample of patients
with schizophrenia and to examine the underlying pathology
of CI in patients with schizophrenia, i.e., by performing
additional structural and functional examinations of the heart,
as CI might rely to a specific cardiovascular pathophysiology
in patients with schizophrenia. Furthermore, schizophrenia
patients with CI do not seem to benefit as well as schizophrenia
patients without CI from moderate continuous aerobic exercise
training interventions, which may explain mixed results in this
population in the literature. Larger, prospective randomized
controlled clinical trials with different training interventions
are urgently needed to address the topic of schizophrenia
patients not responding to exercise and the relationship to the
illness itself.
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